Answer
Urine protein is monitored before and periodically during axitinib treatment because proteinuria, including Grade 3–4 cases, has been reported; moderate to severe proteinuria requires dose reduction or temporary interruption, while nephrotic syndrome requires discontinuation.
Sources for this answer
- Inlyta 5 mg film-coated tabletsPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 17Document updated
Sources checked